AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Adagene Inc. American Depositary Shares
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00YZ6BZC0
2.41▼ 0.03 (-1.23%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
2.44
Day's Range
2.30 – 2.57
52-Week Range
1.30 – 4.85
Volume
163.6K
Avg Volume
343.8K
Share Statistics
Shares Outstanding
Employees
128
Exchange
XNAS
Listed
2021-02-09
Share count as of December 31, 2025

Adagene Inc. American Depositary Shares (ADAG) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Adagene Inc. American Depositary Shares (ADAG)
What is Adagene Inc. American Depositary Shares's Market Cap?
Adagene Inc. American Depositary Shares's Market Cap is $142.7M, based on as-reported figures from SEC (XBRL) filings.
What is Adagene Inc. American Depositary Shares's Enterprise Value?
Adagene Inc. American Depositary Shares's Enterprise Value is $90.9M, based on as-reported figures from SEC (XBRL) filings.
What is Adagene Inc. American Depositary Shares's Price / Sales?
Adagene Inc. American Depositary Shares's Price / Sales is 18.6×, based on as-reported figures from SEC (XBRL) filings.
What is Adagene Inc. American Depositary Shares's EV / Revenue?
Adagene Inc. American Depositary Shares's EV / Revenue is 11.8×, based on as-reported figures from SEC (XBRL) filings.
What is Adagene Inc. American Depositary Shares's EV / EBITDA?
Adagene Inc. American Depositary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Adagene Inc. American Depositary Shares's Revenue (TTM)?
Adagene Inc. American Depositary Shares's Revenue (TTM) is $7.7M, based on as-reported figures from SEC (XBRL) filings.
What is Adagene Inc. American Depositary Shares's Net Income (TTM)?
Adagene Inc. American Depositary Shares's Net Income (TTM) is -$17.6M, based on as-reported figures from SEC (XBRL) filings.
What is Adagene Inc. American Depositary Shares's EBITDA?
Adagene Inc. American Depositary Shares's EBITDA is -$21.0M, based on as-reported figures from SEC (XBRL) filings.
What is Adagene Inc. American Depositary Shares's Diluted EPS (TTM)?
Adagene Inc. American Depositary Shares's Diluted EPS (TTM) is -0.30, based on as-reported figures from SEC (XBRL) filings.
What is Adagene Inc. American Depositary Shares's EBITDA Margin?
Adagene Inc. American Depositary Shares's EBITDA Margin is -273.8%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · ADAGAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018
Revenue
Licensing and collaboration revenue
YoY growth+7332.8%
Operating expenses and income
Research and development expenses
Administrative expenses
Other operating income, net—
Loss from operations
% of revenue-279.5%
Interest and investment income
Interest expense
Other income, net
Foreign exchange gain (loss), net
Change in fair value of warrant liabilities
Loss before income tax
Income tax benefit (expense)
Net loss attributable to Adagene Inc.'s shareholders
% of revenue-229.6%
Total comprehensive loss attributable to Adagene Inc.'s shareholders
Net Income
% of revenue-229.6%
Net loss attributable to ordinary shareholders
Basic (in dollars per share)
Diluted (in dollars per share)